Virium Pharma
0754.431.851 · rovalta.com · 25/09/2026
Virium Pharma
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOVirium Pharma is a Private limited company incorporated in 2020. Its main activity is: Agents involved in the sale of furniture, household goods, hardware and ironmongery. Its registered office is in Aalter.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0754.431.851
- Incorporation
- 15/09/2020
- Legal form
- Private limited company
- Registered office
- Kraenepoelpad 10
9880 Aalter · FlandreSee on map - Contributed capital
- 25 000,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 2,2 k € | -79.8% | 11 k € | +178% | -14,1 k € | -184% | 16,8 k € |
| EBITDA | 925,2 € | -90.4% | 9,6 k € | +163% | -15,2 k € | -196% | 15,9 k € |
| Operating result | 66 € | -95.2% | 1,4 k € | +106% | -23,2 k € | -652% | 4,2 k € |
| Net result | 60 € | -94.5% | 1,1 k € | +105% | -23,5 k € | -1488% | 1,7 k € |
| Balance sheet | |||||||
| Equity | 4,4 k € | +1.4% | 4,3 k € | +34.0% | 3,2 k € | -88.0% | 26,7 k € |
| Total assets | 95,9 k € | -21.7% | 122,5 k € | +13.8% | 107,6 k € | -17.4% | 130,4 k € |
| Cash | 68,3 k € | -29.8% | 97,2 k € | +36.0% | 71,4 k € | -9.2% | 78,7 k € |
| Debts | 91,6 k € | -22.5% | 118,2 k € | +13.2% | 104,4 k € | +0.7% | 103,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Kraenepoelpad 10 9880 Aalter| Company | CBE no. |
|---|---|
CWINVEST● Active | 0444.357.592 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 15/09/2020 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 22 months |
| Filing date | 02/01/2026 | 28/12/2024 | 29/01/2024 | 31/01/2023 |
| General meeting | 05/12/2025 | 06/12/2024 | 01/12/2023 | 02/12/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other17/09/2020RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202560 €↓
- 2024Annual accounts 20241,1 k €↑
- 2023Annual accounts 2023-23,5 k €↓
- 2022Annual accounts 20221,7 k €
- 15/09/2020IncorporationPrivate limited company